Carlijn van der Aalst

Dr. Carlijn van der Aalst is a researcher affiliated with the Public Health department at Erasmus MC, part of Erasmus University Rotterdam. Her work focuses on lung cancer screening, cardiovascular disease prevention, and the integration of artificial intelligence (AI) in medical diagnostics. She collaborates extensively on multi-disciplinary projects addressing early disease detection and public health policy.

Her research interests include optimizing lung cancer screening protocols, evaluating AI-driven diagnostic tools, and studying cardiovascular outcomes in high-risk populations. Notable projects include the 4-IN-THE-LUNG-RUN trial exploring AI's role in reducing clinical referral rates and investigations into coronary artery calcium scores post-salpingo-oophorectomy.

Recent publications highlight trends in AI applications for lung cancer detection and systemic reviews of tumor growth kinetics. Her work bridges clinical practice with population health strategies, emphasizing cost-effective early intervention.

Dr. van der Aalst has supervised two academic works and contributes to large-scale research networks. She engages in multidisciplinary teams focused on translational oncology and preventive cardiology, leveraging computational methods to improve diagnostic accuracy and patient outcomes.